CClinicalTrials.gg
Status unknownNCT01139086Updated Jun 8, 2010

Role of Endothelial Function, Muscular Fitness and Metabolism in Functional Activity in Patients With Chronic Heart Failure (CHF)

An observational study in Chronic Heart Failure, Coronary Disease and Dilated Cardiomyopathy, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to male participants aged 40 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-06-08.

Sponsored by National Taiwan University Hospital · Observational

The sponsor has not verified this record recently (last verified Jun 2010), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
100
Ages
40 Years to 75 Years
Sex
Male
01

Study summary

Shortness of breath, fatigue, and exercise intolerance are clinical symptoms of chronic heart failure (CHF). Recent studies suggested that peripheral impairment was the major cause of clinical symptoms, and mechanism may be related to neuroendocrine impairment and vascular smooth muscle dysfunction. It results in increased peripheral resistance that may influence limb blood flow, muscle fitness and activities of daily.The purposes of this study are

  1. to compare muscular strength, endurance, and perfusion of quadriceps between CHF patients and healthy controls by isokinetic test and near-infrared spectroscopy (NIRS) and difference in activities of daily living
  2. to compare endothelium function between CHF patients and healthy control subjects
  3. the relationship between endothelium function, muscular strength, endurance, perfusion, and metabolism of quadriceps.
02

Conditions studied

  • Chronic Heart Failure
  • Coronary Disease
  • Dilated Cardiomyopathy

Keywords

  • chronic heart failure
  • isokinetic test
  • near-infrared spectroscopy
  • laser Doppler flowmetry
  • endothelial function
03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 100 is below the median of 200 across 1,679 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Chronic Heart Failure Coronary Disease Dilated Cardiomyopathy Control group without diagnosis of any heart disease

Inclusion criteria

  • Age 40-75 years
  • Chronic heart failure: ejection fraction\<40% and at stable condition
  • Coronary Disease and dilated cardiomyopathy without heart failure
  • Control group without diagnosis of any heart disease

Exclusion criteria

Exclusion Criteria:

  • Clinical diagnosis of neuromusculoskeletal , pulmonary, or other systemic diseases that may affect the testing of the study
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)

Groups and cohorts

  • Cardiovascular disease

    Diagnosis of cardiomyopathy or ischemic heart disease without heart failure

  • Chronic heart failure

    Diagnosis of cardiomyopathy or ischemic heart disease LVEF \<40%

  • Control

    Age and body built matched with chronic heart failure group

06

What researchers measure

Primary outcomes

  1. muscle strength and endurance

    Measured by biodex

    Time frame: baseline

Secondary outcomes

  1. skeletal muscle oxygenation response

    Measured by near-infrared spectroscopy

    Time frame: baseline

  2. Walking distance in 6-minute walking test

    walking distance (m)

    Time frame: baseline

  3. laser Doppler flowmetry combine iontophoresis

    To measure the blood flux (PU) response to Ach (endothelial-dependent agent) and SNP (endothelial-independent agent)

    Time frame: baseline

  4. sit-to-stand test

    Measured times in 1 minute

    Time frame: baseline

  5. questionnaire (functional activity and quality of life)

    Time frame: baseline

  6. Analysis of venous blood sample

    By standard venipuncture

    Time frame: baseline

07

Study locations

1 of 1 sites recruiting
  • National Taiwan University Hospital
    Taipei City, 100, Taiwan
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01139086
Lead sponsor
National Taiwan University Hospital
First posted
Jun 8, 2010
Start date
May 2010
Primary completion
May 2011 (estimated)
Completion
May 2011 (estimated)
Last update
Jun 8, 2010

Study contacts

Ying-Tai Wu, Ph.D
Contact
ytw@ntu.edu.tw
+886-2-33668129
Ying-Tai Wu, Ph.D
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion